Other mucopurulent conjunctivitis, bilateral
ICD-10 H10.023 is a billable code used to indicate a diagnosis of other mucopurulent conjunctivitis, bilateral.
H10.023 refers to other mucopurulent conjunctivitis affecting both eyes. Clinically, this condition presents with symptoms such as redness, discharge, and irritation of the conjunctiva, which is the thin membrane covering the white part of the eye and the inner eyelids. The mucopurulent discharge is typically yellow or green, indicating a bacterial infection. The conjunctiva, sclera, and cornea may be involved, leading to potential complications if left untreated, such as corneal ulceration or scarring. Disease progression can vary; acute cases may resolve with appropriate treatment, while chronic cases may require more extensive management. Diagnostic considerations include a thorough history and physical examination, culture of the conjunctival discharge, and possibly conjunctival scrapings to identify the causative organism. Differential diagnoses include viral conjunctivitis and allergic conjunctivitis, which may present similarly but require different management strategies.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
H10.023 covers bilateral mucopurulent conjunctivitis, which may be caused by bacterial infections, including but not limited to Neisseria gonorrhoeae and Chlamydia trachomatis. It is characterized by purulent discharge and conjunctival inflammation.
H10.023 should be used when both eyes are affected by mucopurulent conjunctivitis, distinguishing it from unilateral codes. It is essential to document the bilateral nature and specific symptoms to justify this code.
Documentation should include a detailed clinical examination, noting symptoms such as discharge type, redness, and any associated systemic symptoms. Culture results and treatment plans should also be documented to support the diagnosis.
